Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

InVivo Therapeutics Holdings Corp. (NVIV)

7.12   -0.09 (-1.25%) 02-14 16:00
Open: 7.18 Pre. Close: 7.21
High: 7.8 Low: 6.75
Volume: 159,293 Market Cap: 4M
InVivo Therapeutics Holdings Corp is a research and clinical-stage biomaterials and biotechnology company with a focus on treatment of spinal cord injuries.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.808 - 7.851 7.851 - 7.886
Low: 6.658 - 6.705 6.705 - 6.745
Close: 7.045 - 7.121 7.121 - 7.184

Technical analysis

as of: 2020-02-14 4:31:14 PM
Overall:       
Stoxline posted a NEUTRAL today, same as yesterday. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 9.94     One year: 11.61
Support: Support1: 3.36    Support2: 0.17
Resistance: Resistance1: 8.51    Resistance2: 9.94
Pivot: 1.68
Moving Average: MA(5): 4.58     MA(20): 1.34
MA(100): 0.54     MA(250): 0.83
MACD: MACD(12,26): 1.34     Signal(9): 0.51
Stochastic oscillator: %K(14,3): 87.41     %D(3): 73.47
RSI: RSI(14): 87.25
52-week: High: 8.51  Low: 0.12  Change(%): 405.0
Average Vol(K): 3-Month: 132818  10-Days: 98720

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
NVIV has closed below upper band by 3.1%. Bollinger Bands are 2398.6% wider than normal. The large width of the bands suggest high volatility as compared to NVIV's normal range. The bands have been in this wide range for 2 bars. This is a sign that the current trend might continue.

Headline News

2020-02-03
InVivo Therapeutics Announces Reverse Stock Split
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced a 1-for-30 reverse stock split of its common stock and a proportionate reduction in its authorized common stock. The company anticipates the reverse stock split will become effective at 5:00 p.m. Eastern Time on February 11, 2020, and shares of InVivo Therapeutics common stock will trade on a post-split basis under the Company's existing trading symbol, "NVIV," at the market open on February 12,

2019-11-26
The Daily Biotech Pulse: ChemoCentryx Triples On Data Readout, Global Blood Given FDA Nod, Positive Safety Review For Genfit's NASH Drug
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs on Nov. 25.) ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD ) Alnylam Pharmaceuticals, Inc. (NASDAQ: ALNY ) Amgen, Inc. (NASDAQ: AMGN ) Antares Pharma Inc (NASDAQ: ATRS ) Arrowhead Pharmaceuticals Inc (NASDAQ: ARWR ) Arvinas Inc (NASDAQ: ARVN ) (Guggenheim initiated coverage of stock with Buy rating and $50 price target) Avadel Pharmaceuticals PLC (NASDAQ: AVDL ) (announced achievement of enrollment target in a Phase 3 trial of drug to treat excessive daytime sleepiness and cataplexy in patients with narcolepsy) Axsome Therapeutics Inc (NASDAQ: AXSM ) Beigene Ltd (NASDAQ: BGNE ) Bio-Rad Laboratories, Inc. Class A (NYSE: BIO ) BIO-TECHNE Corp (NASDAQ: TECH ) BioNTech SE – ADR (NASDAQ: BNTX ) Collegium Pharmaceutical Inc (NASDAQ: COLL ) Cue Biopharma Inc (NASDAQ: CUE ) DexCom, Inc. (NASDAQ: DXCM ) Dicerna Pharmaceuticals Inc (NASDAQ: DRNA ) Epizyme Inc (NASDAQ: EPZM ) ESSA Pharma Inc (NASDAQ: EPIX ) Flexion Therapeutics Inc (NASDAQ: FLXN ) GENMAB A/S/S ADR (NASDAQ: GMAB ) Globus Medical Inc (NYSE: GMED ) Halozyme Therapeutics, Inc.

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ Global Market
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 16.52
Shares Float (M) 9.44
% Held by Insiders 0.77
% Held by Institutions 6.93
Shares Short (K) 234
Shares Short P. Month (K)

Stock Financials

EPS -1.184
Book Value (p.s.) 0.820
PEG Ratio
Profit Margin
Operating Margin
Return on Assets (ttm) -45.1
Return on Equity (ttm) -83.4
Qtrly Rev. Growth
Gross Profit (p.s.)
Sales Per Share
EBITDA (p.s.) -0.709
Qtrly Earnings Growth
Operating Cash Flow (M) -11.41
Levered Free Cash Flow (M) -7.45

Stock Valuations

P/E -6.01
P/E Growth Ratio -0.01
P/BV 8.68
P/S
P/CF -10.31

Dividends & Splits

Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date 2018-04-16
Last Split Ratio 0.04
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2019 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.